Updated esc/eacts guidelines mark advancement in structural heart disease care

Madrid--(business wire)--edwards lifesciences (nyse: ew) welcomes the updated esc/eacts guidelines for valvular heart disease, which establish a simplified care pathway for all severe aortic stenosis (as) patients, regardless of symptoms. the guidelines enable a proactive approach to disease management and underscore that intervention should be considered for asymptomatic patients, regardless of heart function, which is a meaningful step forward from the prior practice of “watchful waiting.” th.
EW Ratings Summary
EW Quant Ranking